Clarence Jones

Last thoughts from you, Clarence. I just want our listeners to know we thank you for listening to our chattering today. Because all we did, we didn't come up with any specific research. We just started chatting about motivation. And hopefully it'll spark some thoughts in your mind about, you know, why do you do what you do? So I'm finished. Absolutely. Thank you for listening.

Last thoughts from you, Clarence. I just want our listeners to know we thank you for listening to our chattering today. Because all we did, we didn't come up with any specific research. We just started chatting about motivation. And hopefully it'll spark some thoughts in your mind about, you know, why do you do what you do? So I'm finished. Absolutely. Thank you for listening.

I was out in the country and I could, and my internet was not that good. I heard part of that. Yeah. I heard part of that. And I think that part of, uh,

I was out in the country and I could, and my internet was not that good. I heard part of that. Yeah. I heard part of that. And I think that part of, uh,

What I'm glad we're having this conversation is that I recently was working with Dr. Niloufar Hadidi at the University of Minnesota on an African-American stroke project where we're talking about some of the same things is how do you make people aware? What should people know? And then how do you communicate with your doctor about whatever the condition was?

What I'm glad we're having this conversation is that I recently was working with Dr. Niloufar Hadidi at the University of Minnesota on an African-American stroke project where we're talking about some of the same things is how do you make people aware? What should people know? And then how do you communicate with your doctor about whatever the condition was?

We just happened to be talking about strokes. But I'm really glad, Tony, that you're telling your story because I think that you know, many people don't really understand the nuances that happen with these issues and why it's so important for us to, first of all, to know ourselves, what's going on, but also to be able to communicate with our doctors.

We just happened to be talking about strokes. But I'm really glad, Tony, that you're telling your story because I think that you know, many people don't really understand the nuances that happen with these issues and why it's so important for us to, first of all, to know ourselves, what's going on, but also to be able to communicate with our doctors.

Right.

Right.

Right.

Right.

You know, I want to say that I want to say this real quickly, though. And Tony, I totally understand you, because that's one of the it's one of the challenges for us, you know, in terms of the work that we do is that there are people that are very skeptical of the of the system. OK.

You know, I want to say that I want to say this real quickly, though. And Tony, I totally understand you, because that's one of the it's one of the challenges for us, you know, in terms of the work that we do is that there are people that are very skeptical of the of the system. OK.

And I think people like myself who who've had a chance to kind of work with the system, we understand that that's not that's not always in the majority of the cases the issue. Sometimes we just have we have, as you just said, because of the mistrust, people will not will not trust. do a study, but those things also in the, on the other hand, those things impact us as well.

And I think people like myself who who've had a chance to kind of work with the system, we understand that that's not that's not always in the majority of the cases the issue. Sometimes we just have we have, as you just said, because of the mistrust, people will not will not trust. do a study, but those things also in the, on the other hand, those things impact us as well.

I don't know if you know that. I mean, I know you know that, but, but because we're not involved in the studies, many times when the medicines come out, they don't necessarily work as effectively for us as they do for other people.

I don't know if you know that. I mean, I know you know that, but, but because we're not involved in the studies, many times when the medicines come out, they don't necessarily work as effectively for us as they do for other people.

Well, let me say this real quick. I think I think this is really good that we're entering into this kind of candid, open, honest conversation. And we're being very, very transparent. This is a issue that that, you know, that many, many, many people in our communities face. You know, it was interesting.

Well, let me say this real quick. I think I think this is really good that we're entering into this kind of candid, open, honest conversation. And we're being very, very transparent. This is a issue that that, you know, that many, many, many people in our communities face. You know, it was interesting.